                               SEQUENCE LISTING

<110> TUFTS MEDICAL CENTER
      TRUSTEES OF TUFTS COLLEGE
 
<120> METHODS AND SYSTEMS FOR DESIGNING AND/OR CHARACTERIZING 
      SOLUBLE LIPIDATED LIGAND AGENTS

<130> 2011149-0003

<140> PCT/US2014/026662
<141> 2014-03-13

<150> 61/813,835
<151> 2013-04-19

<150> 61/811,249
<151> 2013-04-12

<160> 19    

<170> PatentIn version 3.5

<210> 1
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> s-Chem 149-157 (commercial source)

<400> 1
Tyr Phe Pro Gly Gln Phe Ala Phe Ser 
1               5                   


<210> 2
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> I-Chem 149-157

<400> 2
Lys Gly Gly Tyr Phe Pro Phe Gln Phe Ala Phe Ser 
1               5                   10          


<210> 3
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> s-Stable Chem

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Tic

<400> 3
Tyr Phe Leu Pro Ser Gln Phe Ala Xaa Ser 
1               5                   10  


<210> 4
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> I-Stable Chem

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Tic

<400> 4
Gly Gly Tyr Phe Leu Pro Ser Gln Phe Ala Xaa Ser 
1               5                   10          


<210> 5
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> Ac2-KGG-Chem9

<400> 5
Lys Gly Gly Tyr Phe Pro Phe Gln Phe Ala Phe Ser 
1               5                   10          


<210> 6
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> PA-PEG8-K(Ac)GG-Chem9

<400> 6
Lys Gly Gly Tyr Phe Pro Phe Gln Phe Ala Phe Ser 
1               5                   10          


<210> 7
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> PA-PEG12-K(NBD)GG-Chem9

<400> 7
Lys Gly Gly Tyr Phe Pro Phe Gln Phe Ala Phe Ser 
1               5                   10          


<210> 8
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> PEG8-stable-Chem9

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Tic

<400> 8
Gly Gly Tyr Phe Leu Pro Ser Gln Phe Ala Xaa Ser 
1               5                   10          


<210> 9
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> Stearic Acid-PEG8-Chem9

<400> 9
Lys Gly Gly Tyr Phe Pro Phe Gln Phe Ala Phe Ser 
1               5                   10          


<210> 10
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> FGPA-PEG8-Chem9

<400> 10
Lys Gly Gly Tyr Phe Pro Phe Gln Phe Ala Phe Ser 
1               5                   10          


<210> 11
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> Oleic Acid-PEG8-Chem9

<400> 11
Lys Gly Gly Tyr Phe Pro Phe Gln Phe Ala Phe Ser 
1               5                   10          


<210> 12
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> Eladic Acid-PEG8-Chem9

<400> 12
Lys Gly Gly Tyr Phe Pro Phe Gln Phe Ala Phe Ser 
1               5                   10          


<210> 13
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> Cholestrol-PEG8-Chem9

<400> 13
Lys Gly Gly Tyr Phe Pro Phe Gln Phe Ala Phe Ser 
1               5                   10          


<210> 14
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> s-SubP-COOH

<400> 14
Arg Pro Lys Pro Gln Gln Phe Phe Gly Leu Met 
1               5                   10      


<210> 15
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> CCK4

<400> 15
Trp Met Asp Phe 
1               


<210> 16
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> s-CCK4-Gly-COOH

<400> 16
Trp Met Asp Phe Gly 
1               5   


<210> 17
<211> 91
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 17
Met Ser Thr Ser Met Ile Arg Asp Val Glu Leu Ala Glu Glu Ala Leu 
1               5                   10                  15      


Pro Lys Lys Thr Gly Gly Pro Gln Gly Ser Arg Arg Cys Leu Phe Ser 
            20                  25                  30          


Leu Phe Ile Val Ala Gly Ala Thr Thr Leu Phe Cys Leu Leu His Phe 
        35                  40                  45              


Gly Val Ile Gly Ser Gly Asn Gly Asn Gly Asn Gly Asn Gly Asn Gly 
    50                  55                  60                  


Asn Gly Asn Gly Asn Gly Asn Gly Asn Glu Gln Lys Leu Ile Ser Glu 
65                  70                  75                  80  


Glu Asp Leu Gly Asn Gly Asn Gly Asn Gly Ser 
                85                  90                


<210> 18
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> I-SubP-COOH

<400> 18
Lys Gly Gly Arg Pro Lys Pro Gln Gln Phe Phe Gly Leu Met 
1               5                   10                  


<210> 19
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> I-CCK4-Gly-COOH

<400> 19
Gly Gly Trp Met Asp Phe Gly 
1               5           


